NAVA — Navamedic ASA Income Statement
0.000.00%
Last trade - 00:00
- NOK590.03m
- NOK703.49m
- NOK512.00m
- 49
- 26
- 34
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 189 | 210 | 278 | 382 | 512 |
Cost of Revenue | |||||
Gross Profit | 57.6 | 70.3 | 112 | 164 | 199 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 199 | 215 | 267 | 328 | 488 |
Operating Profit | -10.1 | -4.93 | 11.5 | 54 | 23.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.5 | -16.6 | 2.36 | 42.5 | 10.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.3 | -16.5 | 0.618 | 29.4 | 3.81 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 27.9 | -16.5 | 0.618 | 29.4 | 3.81 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27.9 | -16.5 | 0.618 | 29.4 | 3.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.39 | -1.14 | 0.038 | 1.33 | 0.22 |
Dividends per Share |